Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01091428Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerTreatment
NCT01447706A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian CancersTreatment